Pharmaceutical Investing Acerus Updates on Temporary Unavailability of NATESTO in Canada and South Korea
Pharmaceutical Investing VIDEO - Acerus Pharma CEO: Keeping Focus on Drug Delivery Tech, Not Cannabis
Acerus Receives Notice of Deficiency – Withdrawal Letter from Health Canada Regarding Gynoflor Application
